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The human recombinant histamine releasing factor (HrHRF), also known as translationally controlled tumor protein (TCTP), p23 and
fortilin, has been described to have both extra- and intracellular functions. To elucidate an extra- or intracellular role for HrHRF, we used the
yeast two-hybrid system with HrHRF as the bait and a Jurkat T cell library. We isolated a partial cDNA clone of the human elongation factor-
1 delta (EF-1y) encoding for amino acids 12 to 281. This interaction was confirmed by co-immunoprecipitation experiments. Previously, both
HrHRF and EF-1y have been isolated and identified in association with malignancy in numerous studies. EF-1y is part of the EF-1 complex
responsible for kinetic proofreading in protein synthesis. Additionally, DNA microarray data classifies TCTP (HrHRF) as co-regulated with
ribosomal proteins and recent structural analysis of TCTP (HrHRF) relates it to a guanine nucleotide-free chaperone. Our findings of an
interaction between HrHRF and EF-1y taken with some of the recently published information concerning the TCTP (HrHRF) mentioned
above suggest a possible intracellular role for TCTP/HrHRF.
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eElongation factor-1B beta1. Introduction
The translationally controlled tumor protein (TCTP)
was originally identified in the 1980s by Brawerman’s
group as a tumor protein in a mouse ascitic tumor and in
mouse erythroleukemia. However, no function for the
protein was identified [1,2]. In 1995, we described for
the first time a function of the molecule, namely identify-
ing it as a stimulus of histamine release from human0925-4439/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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E-mail address: smacdona@jhmi.edu (S.M. MacDonald).basophils [3]. Thus, TCTP, also known as p23 and the
IgE-dependent histamine releasing factor (HRF), is be-
lieved to play an important role in the chronic allergic
disease process. HRF was initially described as a complete
secretogogue for histamine and IL-4 secretion from baso-
phils of a subset of allergic donors [4]. Initially, it was
thought that these donors had a certain type of IgE that
interacted with HRF to induce secretion [5]. However, it
subsequently was demonstrated that HRF primed all baso-
phils for histamine release as well as IL-4 and IL-13
secretion, regardless of the type of IgE [5]. Additional
data demonstrated that HRF did not appear to interact with
IgE. First, pharmacologic agents that altered HRF-induced
histamine release (e.g. rottlerin) did not affect anti-IgE-
induced release [6]. Second, rat basophilic leukemia (RBL)
cells transfected with the a, h, and g chains of the human
IgE receptor, FcqRI, did not release histamine to HRF
despite sensitization with IgE molecules from an HRF-
responder [7]. Third, HRF was shown to stimulate eosi-
nophils to produce IL-8 and a calcium response [8]. This
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which does not express the a chain of the FcqRI, and
therefore cannot bind IgE with high affinity. Finally, HRF
has been shown by flow cytometry to bind to the Jurkat T
cell line (unpublished data) and to inhibit cytokine pro-
duction from stimulated primary T cells [9]. Because HRF
is not dependent on the IgE molecule for its biologic
functions, we subsequently have designated it as the
human recombinant HRF (HrHRF). More recently, another
group has identified this molecule as a B cell growth factor
[10]. This group demonstrated that it bound to B cells and
induced cytokine production from these cells. Additionally,
HrHRF was shown to stimulate bronchial epithelial cells to
produce IL-8 and granulocyte/macrophage colony-stimu-
lating factor [11]. Because of its bioactivity, the search for
a specific HrHRF/TCTP receptor is ongoing in several
laboratories.
Despite the extracellular functions of HrHRF/TCTP in
allergic disease, the protein does not have a hydrophobic
leader sequence that is typical of a secreted protein [3],
and it is found abundantly in the cytoplasm [12]. Further-
more, HrHRF/TCTP is ubiquitously detected in most cell
types [3,13] and is highly conserved throughout a wide
range of species [14–18]. These data suggest that HrHRF/
TCTP may be important in cell functioning, and that
HrHRF/TCTP may have an intracellular as well as an
extracellular function. Recently, one group identified an
anti-apoptotic function of HrHRF/TCTP and renamed the
molecule fortilin [19].
There are precedents in the literature for a protein to have
both intra- and extracellular functions. For instance, galec-
tins belong to members of an animal lectin family that is
defined by their affinity for h-galactose-containing oligo-
saccharides and their shared consensus amino acid sequen-
ces [20]. Similar to HrHRF/TCTP this family is highly
conserved [21]. One member of the family, galectin 3, has
no hydrophobic leader sequence, but has documented extra-
and intracellular functions. For example, by virtue of its
ability to recognize cell surface glycoproteins, it has been
shown to activate several cell types (including human
neutrophils and monocytes) and inhibit IL-5 production
from eosinophils [20]. Additionally, it has been shown to
bind to Bcl-2 in vitro [21] and to render cells more resistant
to apoptosis by a mechanism that appears to involve direct
interactions with intracellular proteins [22].
The present study was undertaken to elucidate either
intracellular or extracellular HrHRF/TCTP interactions using
a yeast two-hybrid system with full-length HrHRF as the bait.2. Materials and methods
2.1. Yeast two-hybrid system
The Hybrid Hunterk yeast two-hybrid system (Invitro-
gen, Carlsbad, CA) was used. The HrHRF was cloned inframe into the pHybLex/Zeo vector to create a LexA DNA
binding domain (DBD)/HrHRF fusion protein. The expres-
sion of the bait was confirmed in the Saccharomyces
cerevisiae L40 yeast strain. The bait strain was also tested
and found to be free of nonspecific activation of the
reporter genes. The commercially available cDNA library
for the Jurkat cells, a human T cell leukemia line (Invi-
trogen), was chosen for screening based on our previous
demonstration of HrHRF’s ability to inhibit cytokine
production from this cell line [9]. The cDNA library was
expressed in the pYESTrp vector, which creates B42
activation domain (B42AD)/T cell library fusion proteins,
and contains the TRP1 gene for auxotrophic selection of
the plasmid. The yeast strain L40 contained two reporter
genes, lacZ and the auxotrophic marker, HIS3. Transcrip-
tional activity of these reporter genes was reconstituted
when the DBD and B42AD are joined by a protein–
protein interaction between the HrHRF and a T cell library
protein. Consequently, any protein–protein interaction be-
tween the HrHRF and a T cell library protein was detected
by colony growth on histidine-deficient media and con-
firmed by a h-galactosidase production assay, generating
double-positive clones. The h-galactosidase activity was
assayed using a filter lift assay [23]. Yeast DNA from each
double positive clone was extracted, transformed into E.
coli, grown into mini preps from which DNA was purified
and then sequenced at the Johns Hopkins DNA Analysis
Facility using the vector specific primers provided (Hybrid
Hunterk, Invitrogen).
2.2. Immunoprecipitations
The cDNA for EF1y (12-281), clone 320#3, was cloned
into the PRSET A vector (Invitrogen) to create a fusion
protein with the Xpress tag sequence. The vector with
insert was transformed into TOP 10 E. coli cells (Invitro-
gen) for maintenance and the insert was sequenced to
confirm that the sequence was in frame. The protein was
expressed in the E. coli BL21(DE3)pLysS cells (Invitro-
gen) and protein production was confirmed by Western
blot using the anti-Xpress antibody (1:5000 = 220 ng/ml),
as per manufacturer’s instructions (Invitrogen). Protein
production was accomplished by standard methods of
bacterial growth in the presence of ampicillin, followed
by 0.5 mM isopropyl-beta-D-thiogalactopyranoside (IPTG)
induction. Suspensions were centrifuged (10 min at
300 g) and the cell pellets were frozen. Lysates were
made in RIPA 50 buffer (50 mM Tris–HCl, 50 mM NaCl,
1% Nonidet P-40, 1% sodium deoxycholate, 0.1% SDS, 2
mM EDTA) in the presence of protease inhibitor cocktail
(BD-Pharmingen Biosciences, San Diego, CA) and under-
went three freeze–thaw cycles. The lysates were diluted
1:100 in RIPA 50, and precleared with 80-Al protein A
Sepharose 4 Fast Flow Beads (Amersham Biosciences,
Uppsala, Sweden) and 1-Ag control IgG antibody (Jackson
ImmunoResearch Labs, West Grove, PA) to reduce nonspe-
Fig. 1. Specific interaction between HrHRF and clone 320#3. The bait
pHybLexZeo/HrHRF plasmid and library pYESTrp2/320#3 plasmid were
co-transfected into the L40 yeast strain and first grown on selective media
to check only for co-expression of the plasmids, i.e. primary transformation
efficiency. Subsequently, these primary transformants were grown on
histidine-deficient media and checked for h-galactosidase activity. In Panel
A, a plate of primary transfectants was lifted onto the nitrocellulose and
then exposed to X-gal for 30 min at 30 jC in the dark. A strong interaction
between proteins is indicated by color development in 30 min, and all
primary transformants showed a strong interaction. In Panel B, primary
transformants were restreaked onto histidine-deficient media and then
assayed for h-galactosidase activity as described. All primary transformants
grew in the absence of histidine and showed h-galactosidase activity after 3
min of development.
Fig. 2. Co-immunoprecipitation of GST-HrHRF fusion protein and Xpress
tagged-EF-1y from cellular lysates is shown. (Panel A) Western blot
analysis for EF-1y using the anti-Xpress antibody (Invitrogen). (Panel B)
Western blot analysis of the same blot after stripping and reprobing with a
monoclonal antibody to HRF. In both Western blots conditions, the
immunoprecipitation with control antibody is negative while the immuno-
precipitation with the anti-GST antibody shows co-immunoprecipitation of
HrHRF and EF-1y.
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of affinity purified GST-HrHRF fusion protein [24] and
rotated at 4jC for 16 h. Then 1 Ag of each antibody was
added, either control rabbit IgG (Jackson ImmunoRe-
search) or anti-GST(z-5) (Santa Cruz Biotechnology, Santa
Cruz, CA), and rotated for an additional 5 h at 4j. Protein
A Sepharose 4 Fast Flow Beads (80 Al) were added to
each and rotated for 2 h at 4j. The beads were washed
three times in RIPA 50 and resuspended in 40-Al 2 SDS
sample buffer (Invitrogen) with 5% h-mercaptoethanol,
boiled for 5 min and stored at  80j until analysis.
Samples were electrophoresed on 4–20% Tris–Glycine
gels (Invitrogen) under denaturing and reducing conditions
and transblotted onto nitrocellulose. Western blots were
performed to detect both the elongation factor-1 delta (EF-
1y) and the HrHRF in the immunoprecipitations as well as
the original lysates. First, the EF-1y fusion protein was
detected using anti-Xpress as the primary antibody
(1:5000), and then anti-mouse HRP (1:10,000) (Amersham
Life Sciences, Uppsala, Sweden) as the secondary anti-
body followed by development with Super Signal West
Pico Chemiluminescent Substrate (Pierce, Rockford, IL).
The same blot was stripped (60jC for 1 h in 69 mM SDS,
62 mM Trizma-base, 0.7% h-mercaptoethanol) and
reprobed with monoclonal anti-HrHRF (1:5000) (a kind
gift of Dr. Hugh Sampson), and developed in the same
manner.3. Results
Over 10 million primary clones were screened for
interaction between HrHRF and the T cell library, and 89
histidine and h-galactosidase double-positive clones were
evaluated. Of the 89 double-positive clones evaluated, one
clone (clone 320#3) matched within the NCBI database in
the correct orientation to a known nucleotide sequence.
The interaction was confirmed by co-transforming the
pHybLexZeo/HrHRF plasmid and the pYESTrp2/320#3
plasmid into the L40 yeast strain and then screened for
growth on selective media and h-galactosidase activity
(Fig. 1).
Sequence analysis of clone 320#3 gave a 878 nucleotide
insert which after searching the NCBI database was found to
be 100% identical to Homo sapiens EF-1y, [accession #
NM032378/gi:25453473]. Further analysis of the predicted
amino acid sequence, adjusting for the open reading frame
of the insert in the pYESTrp2 vector, indicated that the
cDNA insert encoded for the EF 1-y protein from amino
acid number 12 to 281.
The interaction between HrHRF and EF-1y observed in
the yeast two-hybrid system was confirmed by co-immun-
precipitation of both molecules. The results are shown in
Fig. 2. The anti-GST antibody co-immunoprecipitated the
GST-HrHRF (MW 49,000) and Ef-1y (MW 31 kDa + 3 kDa
tag) from a cellular lysate. The control antibody used for
immunoprecipitation showed no nonspecific binding of
these proteins under these conditions. Additionally, there
was no cross-reactivity between these antibodies (data not
shown). Densitometry of the bands for both the immuno-
precipitation and the original lysate indicated that approxi-
mately 0.14% of the EF-1y originally found in the lysate
was co-immunoprecipitated by the GST- HrHRF.
J.M. Langdon et al. / Biochimica et Biophysica Acta 1688 (2004) 232–236 2354. Discussion
As previously mentioned, although HrHRF/TCTP’s ex-
tracellular function has been known for some time, its
intracellular function is unclear. Since HrHRF/TCTP is so
highly conserved throughout species and is so abundant, it
was speculated to be part of normal cell functioning. The
interaction between HrHRF/TCTP and EF-1y may help
elucidate this intracellular role.
EF-1y is a member of the GTP binding elongation factor-
1 (EF-1) protein complex (EF-1a, h, g, y), which mediates
the elongation step of protein synthesis by transferring
aminoacyl-tRNA to 80S ribosomes. Once tRNA molecules
have acquired an amino acid, they form a complex with EF-
1, which binds tightly to both the amino acid end of a tRNA
and to GTP. This complex pairs with the appropriate codon
in an mRNA molecule. When EF-1 hydrolyzes its bound
GTP, EF-1 dissociates from the ribosome allowing protein
synthesis to occur. EF-1 causes most incorrectly bound
tRNA molecules to leave the ribosome without being used
for protein synthesis. Therefore, EF-1 increases the ratio of
correct to incorrect amino acids that are incorporated into
the protein and essentially acts as a proofreader for protein
production [25–27].
The nomenclature of the subunit structure of EF-1 has
evolved. In 1994, Janssen et al. [28] described a model for
the quaternary structure of EF-1 and its mode of interaction
on the ribosome. In that paper, EF-1 was comprised of two
a, one h, one g and one y subunits. Subsequently, in 2002,
Mansilla et al. [29] mapped the human EF-1 complex using
the yeast two-hybrid system. In their model, the eEF-1Bh
subunit corresponded to the EF-1y subunit in the Janssen
paper.
Previously, both EF-1y and HrHRF/TCTP were reported
to be overexpressed in chemoresistant melanoma cell lines
[12]. The authors speculated that the over expression of EF-
1y may indicate an alteration in the general transcription
machinery of the resistant cell lines. Furthermore, HrHRF/
TCTP is highly expressed in mouse tumor cells [2], and has
also been reported in melanomas, hepatoblastoma, gliomas
and lymphomas [13]. Recently, overexpression of the mouse
homologue to EF-1y, TEF-1y, was found to be partially
responsible for the tumorigenesis induced by cadmium [30].
In light of our finding of the interaction between HrHRF/
TCTP and EF-1y, TCTP may have a different intracellular
role.
This is not the first report of identification of a binding
partner for HrHRF uncovered using yeast two-hybrid.
Taesook et al. [31] described a self-interaction of rat HRF/
TCTP. Kim et al. [32] noted an interaction between rat HRT/
TCTP and myosin light chain and, more recently, the
myeloid cell leukemia protein-1, a Bcl-2 homologue,
HrHRF/TCTP [19]. However, several recent reports may
support a more plausible explanation for the interaction
between HrHRF/TCTP and EF-1y. It has been known for
quite some time that EF-1y was active in the nucleotideexchange reaction [33]. Using microarray gene expression
data and support vector analysis, Brown et al. [34] reported
that a particular gene from S. cerevisiae is a protein
homologous to mammalian HrHRF/TCTP and this homo-
logue co-regulated with ribosomal proteins. Biological work
is necessary to determine if co-regulation accurately predicts
function; however, this study suggests that TCTP may be
involved in cytosolic ribosome functions. Further suggestive
evidence of HrHRF/TCTP’s intracellular role is provided by
the structural studies of Thaw et al. [35]. They described the
three-dimensional structure of TCTP from Saccharomyces
pombe by NMR spectroscopy and revealed an unexpected
structural similarity to the Mss4/Dss4 family. The human
GTPase accessory protein Mss4 is a guanine nucleotide-free
chaperone (GFC) as well as a modest enhancer of guanine
nucleotide exchange factor (GEF) activity. The GTPase
binding surface of Mss4 is conserved in the small helix
(H1) of the TCTP family [35]. This structural homology
suggests a potential role for HrHRF/TCTP as a GTPase
accessory protein and a potential function for the interaction
between HrHRF and EF-1y. These data suggest that the
intracellular role for the ubiquitous and highly conserved
HrHRF/TCTP may be in protein translation. Further bio-
logical studies are warranted to directly investigate this
possibility.Acknowledgements
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